Inga Rose
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 2
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Zoran Gatalica (6 shared papers)Omid Hamid (3 shared papers)Anatole Ghazalpour (2 shared papers)Gargi D. Basu (2 shared papers)Daniel D. Von Hoff (2 shared papers)Nianqing Xiao (2 shared papers)Daniel A. Holterman (2 shared papers)Semir Vranić (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Proceedings of the National Academy of Sciences (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)Annals of Diagnostic Pathology (1 paper)Geburtshilfe und Frauenheilkunde (1 paper)
- Partner nations
- United StatesQatarBosnia and Herzegovina
In The Last Decade
Inga Rose
9 papers receiving 448 citations
Peers
Comparison fields: 5 of 47
- Oncology 307
- Immunology 123
- Cancer Research 56
- Pathology and Forensic Medicine 50
- Pulmonary and Respiratory Medicine 84
Countries citing papers authored by Inga Rose
This map shows the geographic impact of Inga Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Rose more than expected).
Fields of papers citing papers by Inga Rose
This network shows the impact of papers produced by Inga Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Rose. The network helps show where Inga Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Inga Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 418 | |
| 2 | 2016 | 8 | |
| 3 | Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours. | 2016 | 6 |
| 4 | 2014 | 6 | |
| 5 | 2017 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2012 | 2 | |
| 8 | 2022 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 2026 | 0 |
About Inga Rose
Inga Rose is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 10 papers that have together received 449 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (2 papers), Folate and B Vitamins Research (1 paper), Gestational Diabetes Research and Management (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Head and Neck Cancer Studies (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (307 citations), Immunology (123 citations), Cancer Research (56 citations), Pathology and Forensic Medicine (50 citations) and Pulmonary and Respiratory Medicine (84 citations). Inga Rose has collaborated with scholars based in United States, Qatar and Bosnia and Herzegovina. Frequent co-authors include Zoran Gatalica, Omid Hamid, Anatole Ghazalpour, Gargi D. Basu, Daniel D. Von Hoff, Nianqing Xiao, Daniel A. Holterman, Semir Vranić, Henry T. Lynch and Todd Maney. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Cancer Epidemiology Biomarkers & Prevention, Annals of Diagnostic Pathology and Geburtshilfe und Frauenheilkunde.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.